FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Who Wins Germany’s Election Next Month?

Germany’s upcoming federal election is scheduled for September…
FDA Authorizes Novavax COVID Vaccine

North Korea Nuclear Reactor Resumes Operations

A nuclear reactor in North Korea that closed from December…
FDA Authorizes Novavax COVID Vaccine

China Will Soon Surpass Russia as Nuclear Threat

China, in the midst of a rapid nuclear weapons buildup, will…